Gynecologic Oncology Specialist in Winterthur (Switzerland): Dr Gesine Meili

Card

Dr Gesine Meili, is head physician and director of the gynecology clinic at the Kantonsspital Winterthur, specializing in gynecologic oncology.

The team led by Dr Gesine Meili at the gynecological tumor center offers comprehensive care, from diagnosis through treatment to follow-up care. Thanks to many years of experience, proven expertise, and close interdisciplinary collaboration with all relevant specialties, patients benefit from comprehensive, personalized care in accordance with the latest medical standards. The patients' personal needs and well-being are always the top priority.

Gynecologic Cancer Treatment in Winterthur with Expertise from the Head Physician

Cancers of the female reproductive organs require highly specialized diagnosis and treatment. Each type of cancer has its own unique characteristics and requires careful coordination of all treatment steps. Under the medical direction of Dr Gesine Meili, patients at the gynecologic tumor center of the Kantonsspitals Winterthur are treated in accordance with the latest scientific findings and established guidelines.

The center combines expertise from various medical fields, including gynecology, medical oncology, radiation oncology, radiology, pathology, visceral surgery, and psycho-oncology. This close collaboration allows to develop individualized treatment plans for each patient. Treatment planning is conducted on an interdisciplinary basis and considers not only the type and extent of the disease but also the patient’s personal circumstances and wishes.

In addition to an accurate diagnosis, modern surgical procedures, drug therapies, and comprehensive follow-up care play a central role. The goal is to provide every patient with the best possible medical care in a trusting environment.

Treating Peritoneal Cancer: State-of-the-Art Interdisciplinary Treatment Options

Peritoneal carcinomatosis, also known as peritoneal cancer, is a particularly complex neoplastic disease. It often develops in connection to advanced gynecological tumors, particularly ovarian cancer. The disease is characterized by the spread of tumor cells to the peritoneum, where they form metastases.

Accurate staging of the tumor is crucial for successful treatment. Modern imaging techniques and specialized diagnostic tests are used for this purpose. Based on this information, the interdisciplinary team develops a personalized treatment plan.

An important part of treatment may involve the surgical removal of as many visible tumor foci as possible. These so-called cytoreductive procedures require a high level of surgical expertise and are carefully planned. Depending on the findings, drug-based cancer therapies are also used as a supplement.

Close collaboration among gynecologic oncologists, oncologists, radiologists, pathologists, and other specialists ensures comprehensive care even in complex clinical situations. Providing continuous support to patients throughout all phases of treatment also helps maintain a high quality of life.

Experienced Specialist in the Treatment of Ovarian Cancer

Ovarian cancer is one of the most challenging gynecological cancers. Because the disease often causes few or nonspecific symptoms in its early stages, it is not uncommon for it to be diagnosed only at an advanced stage.

A thorough diagnostic evaluation forms the basis for further treatment. This includes gynecological examinations, modern imaging, and the evaluation of tissue samples by experienced pathologists. This is followed by the development of a personalized treatment plan within the interdisciplinary tumor board.

Surgery plays a central role in the treatment of ovarian cancer. The goal is to remove as much of the tumor tissue as possible. The extent of the procedure depends on the stage of the disease and is determined on a case-by-case basis. Thanks to her specialization in gynecologic oncology, Dr Gesine Meili has many years of experience in treating ovarian tumors.

Systemic therapies are often used in combination with surgery. The treatment recommended in each individual case depends, among others, on the type of tumor, the stage of the disease, and individual factors.

Structured follow-up care is just as important as the actual tumor treatment. Follow-up visits make it possible to monitor the success of treatment and detect any potential changes at an early stage. At the same time, patients receive support in coping with the physical and emotional challenges that can be associated with cancer.

Cervical Cancer and Uterine Corpus Cancer: Individualized Treatment According to Up-to-Date Standards

Uterine cancers are among the most common types of gynecological cancer. A distinction is made, in particular, between cervical cancer and uterine corpus cancer, which differ in terms of their development, diagnosis, and treatment.

Cervical cancer usually develops from precancerous lesions that can be detected through screening exams. A vaccine is also available to prevent certain virus-associated types of cervical cancer, particularly for younger women. If the disease is diagnosed, the first step is to determine the exact stage of the tumor. Based on this, a personalized treatment plan is developed.

Uterine corpus cancer occurs primarily after menopause and is often indicated by abnormal bleeding after menopause. Early diagnosis is also crucial for planning further treatment.

Depending on the specific circumstances of the disease, various treatment options are available. Surgery is often the most important step in treatment. In certain cases, additional treatments may be necessary to reduce the risk of relapse or further improve the chances of recovery.

At the Gynecologic Oncology Center, patients benefit from close coordination among all participating medical disciplines. This allows even complex disease courses to be assessed on an individual basis and treated according to current medical standards. Particular attention is paid to providing patients with comprehensive information and support throughout the entire treatment process.

Rare Gynecological Tumors: Specialized Treatment in Winterthur

Besides the more common gynecological cancers, Dr Gesine Meili also treats rare tumors of the female reproductive organs, including vulvar and vaginal cancers. Because of their rarity, these conditions require special diagnostic and therapeutic expertise.

The treatment of rare types of tumors often poses significant challenges for medical planning. Different forms of therapy frequently need to be tailored to each patient to achieve the best possible outcome. For this reason, patients benefit greatly from the expertise of a specialized cancer center with interdisciplinary structures.

In addition to the actual cancer treatment, the team at the gynecologic tumor center places special emphasis on holistic care. Psycho-oncological support, counseling by specialized professionals, and structured follow-up care help patients cope with the challenges of cancer as effectively as possible.

Thanks to her many years of experience in gynecologic oncology and her role as head of the gynecologic tumor center, Dr Gesine Meili is known for providing highly qualified, patient-centered care. Patients in Winterthur have access to state-of-the-art diagnostics, specialized treatments, and comprehensive care at the highest medical standard.

Please visit the website of the gynecologic tumor center at the Kantonsspital Winterthur for more information.